COMMON STOCK PURCHASE WARRANTSecurity Agreement • May 18th, 2020 • NovaBay Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, TLF Bio Innovation Lab, LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [_______], 2020 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [_______], 2025 (the “Termination Date”) but not thereafter, to subscribe for and purchase from NovaBay Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to [_______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 18th, 2020 • NovaBay Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is effective as of May 13, 2020, between NovaBay Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and TLF Bio Innovation Lab LLC, a Delaware limited liability corporation (the “Purchaser”).
SERVICES AGREEMENTServices Agreement • May 18th, 2020 • NovaBay Pharmaceuticals, Inc. • Pharmaceutical preparations • California
This Services Agreement (“Agreement”) is effective as of April 1, 2020 (“Effective Date”), by and between TLF Bio Innovation Lab LLC, a Delaware limited liability corporation whose principal place of business is at 44 Cypress Street, Brookline, MA 02445 (“Provider”), and NovaBay Pharmaceuticals, Inc. (“Company”), a Delaware corporation whose address is 2000 Powell St. Suite 1150, Emeryville, CA 94608, each separately referred as a “Party” and collectively the “Parties.”
